Injectable lipid emulsions-advancements, opportunities and challenges

AAPS PharmSciTech

Volumn 11, Issue 4, 2010, Pages 1526-1540

  Hippalgaonkar, Ketan ^a   Majumdar, Soumyajit ^a,b   Kansara, Viral ^c  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

biodisposition; lipid emulsions; microfluidization; parenteral formulations; sterilization

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CLARITHROMYCIN; CLEVIDIPINE; CREMOPHOR; CYCLOSPORIN; CYCLOSPORIN A; DIAZEPAM; ETOMIDATE; FLUOSOL DA; LIPID EMULSION; LIPOPROSTAGLANDIN E1; LIPURO; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PHENOBARBITAL; PHYSOSTIGMINE; PROPOFOL; RETINOIC ACID; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; BRONCHOSPASM; CRITICAL ILLNESS; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG MARKETING; DRUG SOLUBILITY; DRUG STABILITY; HUMAN; HYPOTENSION; IN VITRO STUDY; INSTRUMENT STERILIZATION; LIPID COMPOSITION; NEPHROTOXICITY; NONHUMAN; PAIN; PARENTERAL NUTRITION; PH MEASUREMENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW; SKIN IRRITATION; SUSTAINED RELEASE FORMULATION; THROMBOPHLEBITIS; TISSUE DISTRIBUTION; VISCOSITY; ZETA POTENTIAL;

CRITICAL ILLNESS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, ESSENTIAL; HUMANS; INFUSIONS, INTRAVENOUS; PARENTERAL NUTRITION; PHARMACEUTICAL VEHICLES; SOLUBILITY; TRIGLYCERIDES;

EID: 78651470720     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9526-5     Document Type: Review

References (159)

1. E Vinnars F Hammarqvist 2004 25th Arvid Wretlind's Lecture-Silver anniversary, 25 years with ESPEN, the history of nutrition Clin Nutr 23 955 62 15380883 10.1016/j.clnu.2004.06.001 (Pubitemid 39243007)
2. A Wretlind 1981 Development of fat emulsions JPEN J Parenter Enteral Nutr 5 230 5 1:CAS:528:DyaL3MXltlWhtr8%3D 6788972 10.1177/0148607181005003230
3. E Vinnars D Wilmore 2003 Jonathan roads symposium papers. History of parenteral nutrition JPEN J Parenter Enteral Nutr 27 225 31 12757118 10.1177/0148607103027003225
4. VE de Meijer KM Gura HD Le JA Meisel M Puder 2009 Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience JPEN J Parenter Enteral Nutr 33 541 7 19571170 10.1177/0148607109332773
5. Raghunathji NB, Albert EC, Madurai G, Charles ES, inventors; Emulsion compositions for the parenteral and/or oral administration of sparingly water soluble ionizable hydrophobic drugs patent EP0215313. 1992.
6. PC Calder GL Jensen BV Koletzko P Singer GJ Wanten 2010 Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions Intensive Care Med 36 735 49 1:CAS:528:DC%2BC3cXktlCrsL8%3D 20072779 10.1007/s00134-009-1744-5
7. DL Waitzberg RS Torrinhas TM Jacintho 2006 New parenteral lipid emulsions for clinical use JPEN J Parenter Enteral Nutr 30 351 67 1:CAS:528: DC%2BD28XnsVGjtL8%3D 16804134 10.1177/0148607106030004351
8. YA Carpentier IE Dupont 2000 Advances in intravenous lipid emulsions World J Surg 24 1493 7 1:STN:280:DC%2BD3M3gtFKgsA%3D%3D 11193713 10.1007/s002680010267 (Pubitemid 32047277)
9. P Furst KS Kuhn 2000 Fish oil emulsions: what benefits can they bring? Clin Nutr 19 7 14 1:CAS:528:DC%2BD3cXisFertLg%3D 10700528 10.1054/clnu.1999.0072 (Pubitemid 30150803)
10. PC Calder 2009 Hot topics in parenteral nutrition. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults Proc Nutr Soc 68 252 60 1:CAS:528:DC%2BD1MXhtV2gsrjP 19426581 10.1017/S0029665109001268
11. FD Battistella JT Widergren JT Anderson JK Siepler JC Weber K MacColl 1997 A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition J Trauma 43 52 8 1:STN:280:DyaK2szpsF2hsw%3D%3D 9253908 10.1097/00005373-199707000-00013 discussion 8-60 (Pubitemid 27334930)
12. P Lenssen BA Bruemmer RA Bowden T Gooley SN Aker D Mattson 1998 Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation Am J Clin Nutr 67 927 33 1:CAS:528:DyaK1cXislaisrs%3D 9583851
13. PT Clayton A Bowron KA Mills A Massoud M Casteels PJ Milla 1993 Phytosterolemia in children with parenteral nutrition-associated cholestatic liver disease Gastroenterology 105 1806 13 1:CAS:528:DyaK2cXhtVGltLY%3D 8253356
14. H Ulrich SM Pastores DP Katz V Kvetan 1996 Parenteral use of medium-chain triglycerides: a reappraisal Nutrition 12 231 8 1:CAS:528:DyaK28XkvVCnsr4%3D 8862527 10.1016/S0899-9007(96)00089-6 (Pubitemid 26286457)
15. B Manuel-y-Keenoy L Nonneman H De Bosscher J Vertommen S Schrans K Klutsch, et al. 2002 Effects of intravenous supplementation with alpha-tocopherol in patients receiving total parenteral nutrition containing medium- and long-chain triglycerides Eur J Clin Nutr 56 121 8 1:CAS:528:DC%2BD38XitVCruro%3D 11857045 10.1038/sj.ejcn.1601294
16. P Radermacher B Santak H Strobach K Schror J Tarnow 1992 Fat emulsions containing medium chain triglycerides in patients with sepsis syndrome: effects on pulmonary hemodynamics and gas exchange Intensive Care Med 18 231 4 1:STN:280:DyaK3s%2FlsFyrtQ%3D%3D 1430588 10.1007/BF01709838
17. CA Gogos FE Kalfarentzos NC Zoumbos 1990 Effect of different types of total parenteral nutrition on T-lymphocyte subpopulations and NK cells Am J Clin Nutr 51 119 22 1:STN:280:DyaK3c7hvFGjtw%3D%3D 2136970
18. CA Gogos N Zoumbos M Makri F Kalfarentzos 1994 Medium- and long-chain triglycerides have different effects on the synthesis of tumor necrosis factor by human mononuclear cells in patients under total parenteral nutrition J Am Coll Nutr 13 40 4 1:STN:280:DyaK2c3gvFGgsQ%3D%3D 8157852
19. AC Bach VK Babayan 1982 Medium-chain triglycerides: an update Am J Clin Nutr 36 950 62 1:CAS:528:DyaL38XmtFClsbc%3D 6814231
20. AC Bach D Storck Z Meraihi 1988 Medium-chain triglyceride-based fat emulsions: an alternative energy supply in stress and sepsis JPEN J Parenter Enteral Nutr 12 82S 8 1:STN:280:DyaL1M7htFanuw%3D%3D 3063844 10.1177/014860718801200610
21. C Chambrier M Lauverjat P Bouletreau 2006 Structured triglyceride emulsions in parenteral nutrition Nutr Clin Pract 21 342 50 1:STN:280: DC%2BD28vkslGiug%3D%3D 16870802 10.1177/0115426506021004342
22. BF Lindgren E Ruokonen K Magnusson-Borg J Takala 2001 Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial Clin Nutr 20 43 8 1:CAS:528:DC%2BD3MXhsVCrsrw%3D 11161543 10.1054/clnu.2000.0156
23. M-T Lin S-L Yeh S-S Tsou M-Y Wang W-J Chen 2009 Effects of parenteral structured lipid emulsion on modulating the inflammatory response in rats undergoing a total gastrectomy Nutrition 25 115 21 1:CAS:528:DC%2BD1cXhsVKltrvL 18834719 10.1016/j.nut.2008.07.015
24. GJ Wanten PC Calder 2007 Immune modulation by parenteral lipid emulsions Am J Clin Nutr 85 1171 84 1:CAS:528:DC%2BD2sXls1KitLg%3D 17490951
25. A Sala-Vila VM Barbosa PC Calder 2007 Olive oil in parenteral nutrition Curr Opin Clin Nutr Metab Care 10 165 74 1:CAS:528:DC%2BD2sXjs1ylsrg%3D 17285004 10.1097/MCO.0b013e32802bf787 (Pubitemid 46220308)
26. A Garcia-de-Lorenzo 2006 Monounsaturated fatty acid-based lipid emulsions in critically ill patients are associated with fewer complications Br J Nutr 95 1029 1:CAS:528:DC%2BD28XkvFOltLc%3D 16611398 10.1079/BJN20061760 (Pubitemid 43805394)
27. DL Waitzberg RS Torrinhas 2009 Fish oil lipid emulsions and immune response: what clinicians need to know Nutr Clin Pract 24 487 99 19605803 10.1177/0884533609339071
28. Diprivan Injectable Emulsion. AstraZeneca. Available at: http://www1.astrazeneca-us.com/pi/diprivan.pdf. Accessed 23 March 2010.
29. Rossi J, Leroux J-C. Principles in the Development of Intravenous Lipid Emulsions. In: Wasan KM, editor. Role of Lipid Excipients in Modifying Oral and Parenteral Drug Delivery. New York: Wiley; 2006. p. 88-123.
30. Floyd AG, Jain S. Injectable emulsions and suspensions. In: Lieberman HA, Rieger MM, Banker GS, editors. Pharmaceutical dosage forms: dispersed systems. New York: Marcel Dekker; 1996. p. 261-310.
31. MY Levy L Langerman S Gottschalk-Sabag S Benita 1989 Side-effect evaluation of a new diazepam formulation: venous sequela reduction following intravenous (i.v.) injection of a diazepam emulsion in rabbits Pharm Res 6 510 6 1:CAS:528:DyaL1MXltValsr0%3D 2762228 10.1023/A:1015928825882
32. O von Dardel C Mebius T Mossberg B Svensson 1983 Fat emulsion as a vehicle for diazepam. A study of 9492 patients Br J Anaesth 55 41 7 10.1093/bja/55.1.41
33. MW Lovell HW Johnson HW Hui JB Cannon PK Gupta CC Hsu 1994 Less-painful emulsion formulations for intravenous administration of clarithromycin Int J Pharm 109 45 57 1:CAS:528:DyaK2cXlsVWmsLk%3D 10.1016/0378-5173(94)90120-1 (Pubitemid 24223185)
34. H Suttmann A Doenicke J Kugler M Laub 1989 A new formulation of etomidate in lipid emulsion-bioavailability and venous provocation Anaesthesist 38 421 3 1:CAS:528:DyaL1MXlvVSmu7Y%3D 2675669
35. D Selander I Curelaru T Stefansson 1981 Local discomfort and thrombophlebitis following intravenous injection of diazepam. A comparison between a glycoferol-water solution and a lipid emulsion Acta Anaesthesiol Scand 25 516 8 1:STN:280:DyaL383otVCisw%3D%3D 7347079 10.1111/j.1399-6576.1981. tb01696.x
36. S Venkataram WM Awni K Jordan YE Rahman 1990 Pharmacokinetics of two alternative dosage forms for cyclosporine: liposomes and intralipid J Pharm Sci 79 216 9 1:CAS:528:DyaK3cXitVCmu74%3D 2338629 10.1002/jps.2600790307
37. PP Constantinides KJ Lambert AK Tustian B Schneider S Lalji W Ma, et al. 2000 Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel Pharm Res 17 175 82 1:CAS:528:DC%2BD3cXitVOqur8%3D 10751032 10.1023/A:1007565230130 (Pubitemid 30158366)
38. A Tibell M Larsson A Alvestrand 1993 Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat Transpl Int 6 69 72 1:STN:280:DyaK3s7ptFyrsw%3D%3D 8447927 10.1111/j.1432-2277.1993. tb00753.x
39. KA Lamb C Washington SS Davis SP Denyer 1991 Toxicity of amphotericin B emulsion to cultured canine kidney cell monolayers J Pharm Pharmacol 43 522 4 1:CAS:528:DyaK3MXkvF2itrw%3D 1682471
40. D Forster C Washington SS Davis 1988 Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes J Pharm Pharmacol 40 325 8 1:CAS:528:DyaL1cXkt1OmtL0%3D 2899626
41. Eccleston GM. Emulsions and Microemulsions. In: Swarbrick J, editor. Encylopedia of Pharmaceutical Technology. New York: Informa Healthcare USA. Inc; 2007. p. 1548-65.
42. Cannon BJ, Shi Y, Gupta P. Emulsions, microemulsions, and lipid-based drug delivery systems for drug solubilization and delivery-Part I: parenteral applications. In: Rong L, editor. Water-Insoluble Drug Formulation. New York: Taylor & Francis; 2008. p. 195-226.
43. PC Rensen MC van Dijk EC Havenaar MK Bijsterbosch JK Kruijt TJ van Berkel 1995 Selective liver targeting of antivirals by recombinant chylomicrons-a new therapeutic approach to hepatitis B Nat Med 1 221 5 1:CAS:528:DyaK2MXksVGnsr0%3D 7585037 10.1038/nm0395-221
44. E Ishida C Managit S Kawakami M Nishikawa F Yamashita M Hashida 2004 Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice Pharm Res 21 932 9 1:CAS:528:DC%2BD2cXktlykuro%3D 15212156 10.1023/B:PHAM.0000029280. 39882.ff (Pubitemid 38870141)
45. W Yeeprae S Kawakami Y Higuchi F Yamashita M Hashida 2005 Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice J Drug Target 13 479 87 1:CAS:528:DC%2BD2MXht1ynsb3N 16332573 10.1080/10611860500293367 (Pubitemid 43347845)
46. AG Floyd 1999 Top ten considerations in the development of parenteral emulsions Pharm Sci Technol Today 2 134 43 1:CAS:528:DyaK1MXns1Gjsb8%3D 10.1016/S1461-5347(99)00141-8 (Pubitemid 29195746)
47. P Kan Z-B Chen C-J Lee IM Chu 1999 Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system J Control Release 58 271 8 1:CAS:528:DyaK1MXitVKnsrk%3D 10099152 10.1016/S0168-3659(98) 00164-3 (Pubitemid 29142451)
48. PP Constantinides A Tustian DR Kessler 2004 Tocol emulsions for drug solubilization and parenteral delivery Adv Drug Deliv Rev 56 1243 55 1:CAS:528:DC%2BD2cXjtl2ktrs%3D 15109767 10.1016/j.addr.2003.12.005 (Pubitemid 38510472)
49. RG Strickley BD Anderson 1993 Solubilization and stabilization of an anti-HIV thiocarbamate, NSC 629243, for parenteral delivery, using extemporaneous emulsions Pharm Res 10 1076 82 1:CAS:528:DyaK3sXmtFSnt7s%3D 8378251 10.1023/A:1018935311304 (Pubitemid 23211435)
50. CJ Herman MJ Groves 1992 Hydrolysis kinetics of phospholipids in thermally stressed intravenous lipid emulsion formulations J Pharm Pharmacol 44 539 42 1:CAS:528:DyaK38XltFygtbs%3D 1357131
51. JJ Wheeler KF Wong SM Ansell D Masin MB Bally 1994 Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol J Pharm Sci 83 1558 64 1:CAS:528:DyaK2cXmtlyhu7k%3D 7891274 10.1002/jps.2600831108 (Pubitemid 24348325)
52. D Papahadjopoulos TM Allen A Gabizon E Mayhew K Matthay SK Huang, et al. 1991 Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc Natl Acad Sci USA 88 11460 4 1:CAS:528:DyaK38XmslWjsg%3D%3D 1763060 10.1073/pnas.88.24.11460
53. F Liu D Liu 1995 Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs Pharm Res 12 1060 4 1:CAS:528:DyaK2MXmvFCks7s%3D 7494803 10.1023/A:1016274801930
54. S Benita D Friedman M Weinstock 1986 Physostigmine emulsion: a new injectable controlled release delivery system Int J Pharm 30 47 55 1:CAS:528:DyaL28Xkt12qurY%3D 10.1016/0378-5173(86)90134-1 (Pubitemid 16101995)
55. MY Levy S Benita 1989 Design and characterization of a submicronized o/w emulsion of diazepam for parenteral use Int J Pharm 54 103 12 1:CAS:528:DyaL1MXls1Sisbo%3D 10.1016/0378-5173(89)90329-3 (Pubitemid 19205235)
56. M Jumaa BW Müller 1999 Physicochemical properties of chitosan-lipid emulsions and their stability during the autoclaving process Int J Pharm 183 175 84 1:CAS:528:DyaK1MXjsFKltr4%3D 10361168 10.1016/S0378-5173(99)00086-1 (Pubitemid 29257963)
57. Buszello K, Muller BW. Emulsions as drug delivery systems. In: Nielloud F, Marti-Mestres G, editors. Pharmaceutical Emulsions and Suspensions. New York: Marcel Dekker; 2000. p. 191-229.
58. PK Hansrani SS Davis MJ Groves 1983 The preparation and properties of sterile intravenous emulsions J Parenter Sci Technol 37 145 50 1:CAS:528:DyaL2cXntlyhuw%3D%3D 6620048
59. C Washington 1996 Stability of lipid emulsions for drug delivery Adv Drug Deliv Rev 20 131 45 1:CAS:528:DyaK28XmtFaitbw%3D 10.1016/0169-409X(95)00116-O (Pubitemid 26284153)
60. S Benita MY Levy 1993 Submicron emulsions as colloidal drug carriers for intravenous administration: comprehensive physicochemical characterization J Pharm Sci 82 1069 79 1:CAS:528:DyaK2cXhsVOjuw%3D%3D 8289116 10.1002/jps. 2600821102 (Pubitemid 24004434)
61. J Han C Washington 2005 Partition of antimicrobial additives in an intravenous emulsion and their effect on emulsion physical stability Int J Pharm 288 263 71 1:CAS:528:DC%2BD2cXhtFGhurrF 15620866 10.1016/j.ijpharm.2004.10.002 (Pubitemid 40038579)
62. Propofol Injectable Emulsion 1%. Hospira Inc. Available at: http://www.hospira.com/Products/productcatalog.aspx. Accessed 11 July 2010.
63. DF Driscoll JG Dunbar A Marmarou 2004 Fat-globule size in a propofol emulsion containing sodium metabisulfite Am J Health Syst Pharm 61 1276 80 1:CAS:528:DC%2BD2cXlvFCltrs%3D 15259759
64. LC Collins-Gold RT Lyons LC Bartholow 1990 Parenteral emulsions for drug delivery Adv Drug Deliv Rev 5 189 208 1:CAS:528:DyaK3MXivF2kuw%3D%3D 10.1016/0169-409X(90)90016-L (Pubitemid 20333024)
65. C Washington SS Davis 1988 The production of parenteral feeding emulsions by Microfluidizer Int J Pharm 44 169 76 1:CAS:528:DyaL1cXksVens70%3D 10.1016/0378-5173(88)90113-5
66. N Innocente M Biasutti E Venir M Spaziani G Marchesini 2009 Effect of high-pressure homogenization on droplet size distribution and rheological properties of ice cream mixes J Dairy Sci 92 1864 75 1:CAS:528: DC%2BD1MXlsFynurs%3D 19389944 10.3168/jds.2008-1797
67. USP. <729>Globule size distribution in Lipid Injectable Emulsions. The United states Pharmacopeia 33/National Formulary 28; 2009. pp. 314-6.
68. USP. Lipid injectable emulsions. The United States Pharmacopeia 33/National Formulary 28; 2009. pp. 3641-3.
69. A Akkar RH Müller 2003 Intravenous itraconazole emulsions produced by SolEmuls technology Eur J Pharm Biopharm 56 29 36 1:CAS:528: DC%2BD3sXltVSrtrg%3D 12837478 10.1016/S0939-6411(03)00063-8 (Pubitemid 36802044)
70. M Singh LJ Ravin 1986 Parenteral emulsions as drug carrier systems J Parenter Sci Technol 40 34 41 1:CAS:528:DyaL28XhslCnsbg%3D 3517276
71. A Akkar RH Müller 2003 Formulation of intravenous Carbamazepine emulsions by SolEmuls® technology Eur J Pharm Biopharm 55 305 12 1:CAS:528:DC%2BD3sXjs1Gjt7Y%3D 12754005 10.1016/S0939-6411(03)00028-6 (Pubitemid 36561557)
72. RH Müller S Schmidt I Buttle A Akkar J Schmitt S Brömer 2004 SolEmuls®-novel technology for the formulation of i.v. emulsions with poorly soluble drugs Int J Pharm 269 293 302 14706241 10.1016/j.ijpharm.2003.09.019 1:CAS:528:DC%2BD3sXhtVSqu7fN (Pubitemid 38045293)
73. JU Junghanns I Buttle RH Muller IB Araujo AK Silva ES Egito, et al. 2007 SolEmuls technology: a way to overcome the drawback of parenteral administration of insoluble drugs Pharm Dev Technol 12 437 45 1:CAS:528:DC%2BD2sXht1Wgt73O 17963143 10.1080/10837450701555885 (Pubitemid 350041531)
74. W Sila-on N Vardhanabhuti B Ongpipattanakul P Kulvanich 2008 Influence of incorporation methods on partitioning behavior of lipophilic drugs into various phases of a parenteral lipid emulsion AAPS PharmSciTech 9 684 92 1:CAS:528:DC%2BC3cXnslGjurg%3D 18496755 10.1208/s12249-008-9089-x
75. J Ferezou AC Bach 1999 Structure and metabolic fate of triacylglycerol- and phospholipid-rich particles of commercial parenteral fat emulsions Nutrition 15 44 50 1:CAS:528:DyaK1MXmtVyhsQ%3D%3D 9918062 10.1016/S0899-9007(98)00130-0 (Pubitemid 29031944)
76. Federal Register 56 (198); 51354, October 11, 1991.
77. Haskell RJ, Shifflett JR, Elzinga PA. Particle-sizing technologies for submicron emulsions. In: Benita S, editor. Submicron emulsions in drug targeting and delivery. Amsterdam: Harwood Academic Publisher; 1998. p. 21-98.
78. Jiao J, Burgess BJ. Characterization and Analysis of Dispersed Systems. In: Burgess BJ, editor. Injectable Dispersed Systems: Formulation, Processing, and Performance. New York: Taylor & Francis; 2005. p. 77-116.
79. I Roland G Piel L Delattre B Evrard 2003 Systematic characterization of oil-in-water emulsions for formulation design Int J Pharm 263 85 94 1:CAS:528:DC%2BD3sXmvValt7g%3D 12954183 10.1016/S0378-5173(03)00364-8 (Pubitemid 37087935)
80. Sherman P. Rheological properties of emulsions. In: Becher P, editor. Encylopedia of Emulsion Technology. New York: Marcel Dekker; 1983. p. 405.
81. CJ Herman MJ Groves 1993 The influence of free fatty acid formation on the pH of phospholipid-stabilized triglyceride emulsions Pharm Res 10 774 6 1:CAS:528:DyaK3sXksFGqtb0%3D 8321844 10.1023/A:1018932421357 (Pubitemid 23152328)
82. DF Driscoll 2006 Lipid injectable emulsions: pharmacopeial and safety issues Pharm Res 23 1959 69 1:CAS:528:DC%2BD28XptVaisrs%3D 16951994 10.1007/s11095-006-9092-4
83. C Washington 1990 Drug release from microdisperse systems: a critical review Int J Pharm 58 1 12 1:CAS:528:DyaK3cXhtVClsLY%3D 10.1016/0378-5173(90) 90280-H (Pubitemid 20034221)
84. C Washington 1989 Evaluation of non-sink dialysis methods for the measurement of drug release from colloids: effects of drug partition Int J Pharm 56 71 4 1:CAS:528:DyaK3cXisFGitg%3D%3D 10.1016/0378-5173(89)90062-8 (Pubitemid 19274692)
85. N Chidambaram DJ Burgess 1999 A novel in vitro release method for submicron sized dispersed systems AAPS PharmSci 1 E11 1:STN:280: DC%2BD3MjgtVKrsg%3D%3D 11741207 10.1208/ps010311
86. Chidambaram N, Burgess BJ. Emulsions: design and manufacturing. In: Burgess BJ, editor. Injectable dispersed systems: formulation, processing, and performance. New York: Taylor & Francis; 2005. p. 213-41.
87. T Tadros P Izquierdo J Esquena C Solans 2004 Formation and stability of nano-emulsions Adv Colloid Interface Sci 108-109 303 18 15072948 10.1016/j.cis.2003.10.023 1:CAS:528:DC%2BD2cXivFGmsbw%3D
88. F Ishii I Sasaki H Ogata 1990 Effect of phospholipid emulsifiers on physicochemical properties of intravenous fat emulsions and/or drug carrier emulsions J Pharm Pharmacol 42 513 5 1:CAS:528:DyaK3cXlvFOrsbc%3D 1980297
89. S Benita MY Levy 1989 Design and characterization of a submicronized o/w emulsion of Diazepam for parenteral use Int J Pharm 54 103 12 10.1016/0378-5173(89)90329-3 (Pubitemid 19205235)
90. M Jumaa BW Müller 1998 The effect of oil components and homogenization conditions on the physicochemical properties and stability of parenteral fat emulsions Int J Pharm 163 81 9 1:CAS:528:DyaK1cXitVeqtbk%3D 10.1016/S0378-5173(97)00369-4 (Pubitemid 28162622)
91. M Jumaa BW Muller 2000 Lipid emulsions as a novel system to reduce the hemolytic activity of lytic agents: mechanism of the protective effect Eur J Pharm Sci 9 285 90 1:CAS:528:DyaK1MXnslGrsLY%3D 10594386 10.1016/S0928-0987(99) 00071-8
92. M Trotta F Pattarino T Ignoni 2002 Stability of drug-carrier emulsions containing phosphatidylcholine mixtures Eur J Pharm Biopharm 53 203 8 1:CAS:528:DC%2BD38Xhs1yltro%3D 11880004 10.1016/S0939-6411(01)00230-2 (Pubitemid 34189795)
93. SM Jafari Y He B Bhandari 2007 Production of sub-micron emulsions by ultrasound and microfluidization techniques J Food Eng 82 478 88 10.1016/j.jfoodeng.2007.03.007 (Pubitemid 46726881)
94. HJ Zeringue ML Brown WS Singleton 1964 Chromatographically homogeneous egg lecithin as stabilizer of emulsions for intravenous nutrition J Am Oil Chem Soc 41 688 91 1:CAS:528:DyaF2cXkvVOms7Y%3D 10.1007/BF02661410
95. F Ishii T Nii 2005 Properties of various phospholipid mixtures as emulsifiers or dispersing agents in nanoparticle drug carrier preparations Colloids Surf B Biointerfaces 41 257 62 1:CAS:528:DC%2BD2MXhvVCgt78%3D 15748821 10.1016/j.colsurfb.2004.12.018 (Pubitemid 40312742)
96. L Rydhag 1979 The importance of the phase behaviour of phospholipids for emulsion stability Fette Seifen Anstrichm 81 168 73 1:CAS:528:DyaE1MXlt1ahtLk%3D 10.1002/lipi.19790810409
97. JT Rubino 1990 The influence of charged lipids on the flocculation and coalescence of oil-in-water emulsions. II: electrophoretic properties and monolayer film studies J Parenter Sci Technol 44 247 52 1:CAS:528: DyaK3MXhslWitLk%3D 2250200
98. T Nii F Ishii 2004 Properties of various phosphatidylcholines as emulsifiers or dispersing agents in microparticle preparations for drug carriers Colloids Surf B 39 57 63 1:CAS:528:DC%2BD2cXpslOqsbk%3D 10.1016/j.colsurfb. 2004.08.017 (Pubitemid 39473354)
99. E Kawaguchi K-i Shimokawa F Ishii 2008 Physicochemical properties of structured phosphatidylcholine in drug carrier lipid emulsions for drug delivery systems Colloids Surf B Biointerfaces 62 130 5 1:CAS:528:DC%2BD1cXhsFygtb8%3D 17988839 10.1016/j.colsurfb.2007.09.027 (Pubitemid 351179249)
100. M Sznitowska S Janicki E Dabrowska K Zurowska-Pryczkowska 2001 Submicron emulsions as drug carriers. Studies on destabilization potential of various drugs Eur J Pharm Sci 12 175 9 1:CAS:528:DC%2BD3cXoslGhtL8%3D 11113636 10.1016/S0928-0987(00)00115-9
101. MJ Groves CJ Herman 1993 The redistribution of bulk aqueous phase phospholipids during thermal stressing of phospholipid-stabilized emulsions J Pharm Pharmacol 45 592 6 1:CAS:528:DyaK3sXls1OlsL8%3D 8105050
102. M Jumaa BW Müller 1998 The stabilization of parenteral fat emulsion using non-ionic ABA copolymer surfactant Int J Pharm 174 29 37 1:CAS:528:DyaK1cXmsFGntLc%3D 10.1016/S0378-5173(98)00222-1 (Pubitemid 28486986)
103. M Jumaa BW Muller 2002 Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability Eur J Pharm Biopharm 54 207 12 1:CAS:528: DC%2BD38XmtlKjt7c%3D 12191693 10.1016/S0939-6411(02)00057-7 (Pubitemid 34919395)
104. PR Chaturvedi NM Patel SA Lodhi 1992 Effect of terminal heat sterilization on the stability of phospholipid-stabilized submicron emulsions Acta Pharm Nord 4 51 5 1:CAS:528:DyaK38XktFCgu7s%3D 1515053
105. YA Carpentier 1989 Intravascular metabolism of fat emulsions: the Arvid Wretlind Lecture, ESPEN 1988 Clin Nutr 8 115 25 1:STN:280:DC%2BD28vhsFGnsg%3D%3D 16837276 10.1016/0261-5614(89)90060-5
106. IE Dupont YA Carpentier 1999 Clinical use of lipid emulsions Curr Opin Clin Nutr Metab Care 2 139 45 1:CAS:528:DyaK1MXmsVarsbY%3D 10453345 10.1097/00075197-199903000-00008 (Pubitemid 129627811)
107. A Kurihara Y Shibayama A Mizota A Yasuno M Ikeda M Hisaoka 1996 Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats Biol Pharm Bull 19 252 8 1:CAS:528:DyaK28Xht1Ogsr8%3D 8850317
108. A Tibell A Lindholm J Sawe G Chen B Norrlind 1995 Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution Pharmacol Toxicol 76 115 21 1:CAS:528:DyaK2MXjsl2ns7g%3D 7746794 10.1111/j.1600-0773.1995.tb00115.x
109. T Hosokawa M Yamauchi Y Yamamoto K Iwata H Mochizuki Y Kato 2002 Role of the lipid emulsion on an injectable formulation of lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist Biol Pharm Bull 25 492 8 1:CAS:528:DC%2BD38XkslWrsLw%3D 11995931 10.1248/bpb.25.492 (Pubitemid 40036741)
110. MM Ames JS Kovach 1982 Parenteral formulation of hexamethylmelamine potentially suitable for use in man Cancer Treat Rep 66 1579 81 1:CAS:528:DyaL38XkslyrsL8%3D 6807543
111. JW Dundee RS Clarke 1989 Propofol Eur J Anaesthesiol 6 5 22 1:STN:280:DyaL1M3jtFKmtQ%3D%3D 2653816
112. Y Lu Y Zhang Z Yang X Tang 2009 Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats Int J Pharm 366 160 9 1:CAS:528:DC%2BD1cXhsFCjurvJ 18835427 10.1016/j.ijpharm.2008.09.008
113. T Takino K Konishi Y Takakura M Hashida 1994 Long circulating emulsion carrier systems for highly lipophilic drugs Biol Pharm Bull 17 121 5 1:CAS:528:DyaK2cXivVSjurg%3D 8148799
114. T Sakaeda K Hirano 1995 O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug J Drug Target 3 221 30 1:STN:280:DyaK283oslOjuw%3D%3D 8705256 10.3109/10611869509015949
115. T Sakaeda K Hirano 1998 O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection J Drug Target 6 119 27 1:CAS:528:DyaK1MXkvFKmsA%3D%3D 9886236 10.3109/10611869808997887
116. S Ganta JW Paxton BC Baguley S Garg 2008 Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion Int J Pharm 360 115 21 1:CAS:528:DC%2BD1cXos12nu7o%3D 18508212 10.1016/j.ijpharm.2008.04.027
117. S Shi H Chen X Lin X Tang 2010 Pharmacokinetics, tissue distribution and safety of cinnarizine delivered in lipid emulsion Int J Pharm 383 264 70 1:CAS:528:DC%2BD1MXhsVCksrzL 19770029 10.1016/j.ijpharm.2009.09.025
118. K Gao J Sun K Liu X Liu Z He 2008 Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel Drug Dev Ind Pharm 34 1227 37 1:CAS:528:DC%2BD1cXht1KrsbbJ 18720137 10.1080/03639040802005057
119. CH Azevedo JP Carvalho CJ Valduga RC Maranhao 2005 Plasma kinetics and uptake by the tumor of a cholesterol-rich microemulsion (LDE) associated to etoposide oleate in patients with ovarian carcinoma Gynecol Oncol 97 178 82 1:CAS:528:DC%2BD2MXis1Grsb8%3D 15790455 10.1016/j.ygyno.2004.12.015 (Pubitemid 40403691)
120. H Matsuo 1998 Preliminary evaluation of AS-013 (prodrug of prostaglandin E1) administration for chronic peripheral arterial occlusive disease Int J Angiology 7 22 4
121. DG Rodrigues DA Maria DC Fernandes CJ Valduga RD Couto OC Ibanez, et al. 2005 Improvement of paclitaxel therapeutic index by derivatization and association to a cholesterol-rich microemulsion: in vitro and in vivo studies Cancer Chemother Pharmacol 55 565 76 1:CAS:528:DC%2BD2MXjslOmt7g%3D 15726368 10.1007/s00280-004-0930-y (Pubitemid 40674632)
122. JH Jang CK Kim HG Choi JH Sung 2009 Preparation and evaluation of 2-(allylthio)pyrazine-loaded lipid emulsion with enhanced stability and liver targeting Drug Dev Ind Pharm 35 363 8 1:CAS:528:DC%2BD1MXjsFGqtb8%3D 19016100 10.1080/03639040802363696
123. Nishikawa M, Takakura Y, Hashida M. Biofate of fat emulsions. In: Benita S, editor. Submicron emulsions in drug targeting and delivery. Amsterdam: Harwood Academic Publisher; 1998. p. 99-118.
124. RJ Deckelbaum PC Calder YA Carpentier 2004 Using different intravenous lipids: underutilized therapeutic approaches? Curr Opin Clin Nutr Metab Care 7 113 5 15075699 10.1097/00075197-200403000-00002 (Pubitemid 40340671)
125. JW Kruimel TH Naber JA van der Vliet C Carneheim MB Katan JB Jansen 2001 Parenteral structured triglyceride emulsion improves nitrogen balance and is cleared faster from the blood in moderately catabolic patients JPEN J Parenter Enteral Nutr 25 237 44 1:CAS:528:DC%2BD3MXmvVansr8%3D 11531213 10.1177/0148607101025005237
126. FL Oliveira SC Rumsey E Schlotzer I Hansen YA Carpentier RJ Deckelbaum 1997 Triglyceride hydrolysis of soy oil vs fish oil emulsions JPEN J Parenter Enteral Nutr 21 224 9 1:STN:280:DyaK2szps1Ortw%3D%3D 9252949 10.1177/0148607197021004224
127. K Qi T Seo Z Jiang YA Carpentier RJ Deckelbaum 2006 Triglycerides in fish oil affect the blood clearance of lipid emulsions containing long- and medium-chain triglycerides in mice J Nutr 136 2766 72 1:CAS:528: DC%2BD28XhtFGqtLbJ 17056798
128. K Qi T Seo M Al-Haideri TS Worgall T Vogel YA Carpentier, et al. 2002 Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions Biochemistry 41 3119 27 1:CAS:528:DC%2BD38XhtVKisrg%3D 11863451 10.1021/bi015770h (Pubitemid 34184643)
129. RC Maranhao AM Tercyak TG Redgrave 1986 Effects of cholesterol content on the metabolism of protein-free emulsion models of lipoproteins Biochim Biophys Acta 875 247 55 1:CAS:528:DyaL28XhtVKrtbc%3D 3080026
130. T Handa Y Eguchi K Miyajima 1994 Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglyceride/phosphatidylcholine emulsions in rats Pharm Res 11 1283 7 1:CAS:528:DyaK2cXmt1OjtLs%3D 7816757 10.1023/A:1018990327466 (Pubitemid 24287407)
131. SB Clark A Derksen DM Small 1991 Plasma clearance of emulsified triolein in conscious rats: effects of phosphatidylcholine species, cholesterol content and emulsion surface physical state Exp Physiol 76 39 52 1:CAS:528: DyaK3MXkt1Wmtrk%3D 2015073
132. NP Lenzo I Martins BC Mortimer TG Redgrave 1988 Effects of phospholipid composition on the metabolism of triacylglycerol, cholesteryl ester and phosphatidylcholine from lipid emulsions injected intravenously in rats Biochim Biophys Acta 960 111 8 1:CAS:528:DyaL1cXktVCgsLc%3D 3358943
133. SB Clark A Derksen 1987 Phosphatidylcholine composition of emulsions influences triacylglycerol lipolysis and clearance from plasma Biochim Biophys Acta 920 37 46 1:CAS:528:DyaL2sXkvFGrsrw%3D 3593755
134. L Illum C Washington SS Davis 1989 The effect of stabilising agents on the organ distribution of lipid emulsions Int J Pharm 54 41 9 1:CAS:528:DyaL1MXls1Sisrw%3D 10.1016/0378-5173(89)90163-4 (Pubitemid 19198399)
135. M-J Lee M-H Lee C-K Shim 1995 Inverse targeting of drugs to reticuloendothelial system-rich organs by lipid microemulsion emulsified with poloxamer 338 Int J Pharm 113 175 87 1:CAS:528:DyaK2MXhvFCisbk%3D 10.1016/0378-5173(94)00193-9 (Pubitemid 24344225)
136. K Ueda Y Yamazaki H Noto Y Teshima C Yamashita T Sakaeda, et al. 2003 Effect of oxyethylene moieties in hydrogenated castor oil on the pharmacokinetics of menatetrenone incorporated in O/W lipid emulsions prepared with hydrogenated castor oil and soybean oil in rats J Drug Target 11 37 43 1:CAS:528:DC%2BD3sXislyisbw%3D 12852439 10.1080/1061186031000086081 (Pubitemid 36527394)
137. I Arimoto C Matsumoto M Tanaka K Okuhira H Saito T Handa 1998 Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions Lipids 33 773 9 1:CAS:528:DyaK1cXlsFOhtLg%3D 9727607 10.1007/s11745-998-0269-8
138. SY Morita K Okuhira N Tsuchimoto A Vertut-Doi H Saito M Nakano, et al. 2003 Effects of sphingomyelin on apolipoprotein E- and lipoprotein lipase-mediated cell uptake of lipid particles Biochim Biophys Acta 1631 169 76 1:CAS:528:DC%2BD3sXhvFaisbo%3D 12633683
139. TG Redgrave V Rakic BC Mortimer JC Mamo 1992 Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with lipid emulsions in rats Biochim Biophys Acta 1126 65 72 1:CAS:528:DyaK38XksVGhs7Y%3D 1606176
140. PR Reddy V Venkateswarlu 2005 Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion J Drug Target 13 543 53 1:CAS:528:DC%2BD2MXhtlGht7zO 16390815 10.1080/10611860500403156 (Pubitemid 43101953)
141. H Chung TW Kim M Kwon IC Kwon SY Jeong 2001 Oil components modulate physical characteristics and function of the natural oil emulsions as drug or gene delivery system J Control Release 71 339 50 1:CAS:528:DC%2BD3MXitlOhs70%3D 11295226 10.1016/S0168-3659(00)00363-1 (Pubitemid 32276053)
142. T Nii F Ishii 2005 Dialkylphosphatidylcholine and egg yolk lecithin for emulsification of various triglycerides Colloids Surf B Biointerfaces 41 305 11 1:CAS:528:DC%2BD2MXhvVCgtL0%3D 15748826 10.1016/j.colsurfb.2004.12.017 (Pubitemid 40312746)
143. A Kurihara Y Shibayama A Mizota A Yasuno M Ikeda K Sasagawa, et al. 1996 Lipid emulsions of palmitoylrhizoxin: effects of composition on lipolysis and biodistribution Biopharm Drug Dispos 17 331 42 1:CAS:528:DyaK28Xjt1Ggu7Y%3D 8743404 10.1002/(SICI)1099-081X(199605)17:4<331::AID-BDD959>3.0.CO;2-B (Pubitemid 26178151)
144. O Lutz Z Meraihi JL Mura A Frey GH Riess AC Bach 1989 Fat emulsion particle size: influence on the clearance rate and the tissue lipolytic activity Am J Clin Nutr 50 1370 81 1:CAS:528:DyaK3cXnsFOguw%3D%3D 2596427
145. T Takino E Nagahama T Sakaeda F Yamashita Y Takakura M Hashida 1995 Pharmacokinetic disposition analysis of lipophilic drugs injected with various lipid carriers in the single-pass rat liver perfusion system Int J Pharm 114 43 54 1:CAS:528:DyaK2MXivVKrtr8%3D 10.1016/0378-5173(94)00211-M (Pubitemid 24377028)
146. A Kurihara Y Shibayama A Mizota A Yasuno M Ikeda K Sasagawa, et al. 1996 Enhanced tumor delivery and antitumor activity of palmitoyl rhizoxin using stable lipid emulsions in mice Pharm Res 13 305 10 1:CAS:528:DyaK28Xht1Oku7Y%3D 8932454 10.1023/A:1016063719541 (Pubitemid 26074196)
147. Cleviprex Injectable Emulsion. Orange book. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/docs/tempai.cfm. Accessed 11 July 2010.
148. AL Erickson JR DeGrado JR Fanikos 2010 Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension Pharmacotherapy 30 515 28 1:CAS:528:DC%2BC3cXntVantLo%3D 20412001 10.1592/phco.30.5.515
149. Klang S, Benita S. Design and evaluation of submicron emulsions as colloidal drug carriers for intravenous adminsitration. In: Benita S, editor. Submicron emulsions in drug targeting and delivery. Amsterdam: Harwood Academic Publishers; 1998. p. 119-52.
150. Klang S, Parnas M, Benita S. Emulsions as drug carriers-possibilities, limitations and future prespectives. In: Muller RH, Benita S, Bohm B, editors. Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Stuttgart: Medpharm Scientific Publishers; 1998. p. 31-60.
151. Wabel C (1998). Influence of lecithin on structure and stability of parenteral fat emulsions. Ph.D. thesis, University Erlangen-Nuremberg.
152. J Wang Y Maitani K Takayama 2002 Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid J Pharm Sci 91 1128 34 1:CAS:528:DC%2BD38XjtFKhu7g%3D 11948551 10.1002/jps.10104 (Pubitemid 34640937)
153. N Chansri S Kawakami F Yamashita M Hashida 2006 Inhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in mice Int J Pharm 321 42 9 1:CAS:528:DC%2BD28Xos12rsbk%3D 16790329 10.1016/j.ijpharm.2006.05.008 (Pubitemid 44247410)
154. S Suzuki S Kawakami N Chansri F Yamashita M Hashida 2006 Inhibition of pulmonary metastasis in mice by all-trans retinoic acid incorporated in cationic liposomes J Control Release 116 58 63 1:CAS:528:DC%2BD28Xht1emsrfJ 17067713 10.1016/j.jconrel.2006.08.025 (Pubitemid 44792300)
155. K Kleberg F Jacobsen DG Fatouros A Müllertz 2010 Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity J Pharm Sci 99 3522 32 1:CAS:528: DC%2BC3cXnvFGrsrk%3D 20564382 10.1002/jps.22122
156. PB Fernandes DJ Hardy D McDaniel CW Hanson RN Swanson 1989 In vitro and in vivo activities of clarithromycin against Mycobacterium avium Antimicrob Agents Chemother 33 1531 4 1:CAS:528:DyaL1MXlvVKqtLg%3D 2530933
157. RC Bravo Gonzalez J Huwyler I Walter R Mountfield B Bittner 2002 Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension Int J Pharm 245 143 51 1:CAS:528:DC%2BD38XntFygsrY%3D 12270251 10.1016/S0378-5173(02) 00339-3 (Pubitemid 35299900)
158. Y Qiu Y Gao K Hu F Li 2008 Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes J Control Release 129 144 50 1:CAS:528:DC%2BD1cXnsFaltbc%3D 18538885 10.1016/j.jconrel.2008.04.019
159. T Sakaeda H Kakushi T Shike K Takano T Harauchi M Hirata, et al. 1998 O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone J Drug Target 6 183 9 1:CAS:528:DyaK1MXkvFKnsw%3D%3D 9888304 10.3109/10611869808997892